We are live on ! Find out more
PIM

Ponoi II Management Portfolio holdings

AUM $38.3M
1-Year Est. Return 32.02%
This Fund
S&P 500
This Quarter Est. Return
-3.23%
1 Year Est. Return
-32.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$131M
AUM Growth
-$6.68M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$37.8M 28.92%
1,298,908
CNST
2
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$36.8M 28.2%
1,574,229
RVMD icon
3
Revolution Medicines
RVMD
$39.6B
$31.4M 24.07%
685,011
NRIX icon
4
Nurix Therapeutics
NRIX
$2.4B
$21.3M 16.34%
686,274
RAPT
5
DELISTED
RAPT Therapeutics
RAPT
$3.23M 2.47%
18,175

Similar funds

Ponoi II Management's Q1 2021 Portfolio in Review

As of Q1 2021, Ponoi II Management held 5 positions worth $131M, down 4.9% from $137M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2021: portfolio turnover was 0%. Ponoi II Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Ponoi II Management's ten largest holdings make up 100% of its $131M portfolio in Q1 2021.
  • Ponoi II Management opened 0 new positions and closed 0 in Q1 2021.
  • Ponoi II Management's portfolio value fell 4.9% quarter-over-quarter to $131M.

Based on Ponoi II Management's 13F filing for Q1 2021, filed 17 May 2021.